HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gurr, W. Articles by Sherwin, R. Search for Related Content PubMed PubMed Citation Articles by Gurr, W. Articles by Sherwin, R. Social Bookmarking                What's this?

RegII Is a ß-Cell Protein and Autoantigen in Diabetes of NOD Mice

From the Section of Endocrinology, Yale University School of Medicine, New Haven, Connecticut

Address correspondence and reprint requests to Werner Gurr, Yale University School of Medicine, Section of Endocrinology, New Haven, CT 06520-8020. E-mail: werner.gurr{at}yale.edu

Abbreviations: CtfrII, C-terminal fragment of RegII; HIP, hepatocellular carcinoma intestine pancreas; IL, interleukin; NtfrII, N-terminal fragment of RegII; PAP, pancreatitis-associated protein; TGF, transforming growth factor; TNF, tumor necrosis factor

The Reg family of proteins has been studied in the context of growth and regeneration in several organs including pancreatic islets. We previously suggested that Reg proteins act as autoantigens in type 1 diabetes, based on evidence that a member of the Reg family (hepatocellular carcinoma intestine pancreas [HIP]/pancreatitis-associated protein [PAP]) was overexpressed in the islets of a patient who died after sudden onset of type 1 diabetes, and that, in NOD mice, Reg-specific T-cells adoptively transferred diabetes. In the current study, we developed antisera to detect individual Reg members in mouse islets and found that RegIII was present in the non–ß-cell portion of the islets, while RegII was predominantly expressed in ß-cells. Vaccination of NOD mice with the separately expressed N-terminal (NtfrII) or C-terminal (CtfrII) portion of RegII revealed a dichotomy: NtfrII vaccination accelerated and CtfrII vaccination delayed type 1 diabetes. Vaccination with CtfrII was more effective when given at later stages in the pathogenesis of type 1 diabetes, a time dependency different from that seen with other antigen-dependent vaccine strategies in NOD mice, which might have therapeutic implications. In conclusion, RegII is a novel ß-cell–derived autoantigen in NOD mice. The autoimmune response against this protein may convert a regenerative into an islet-destructive process accelerating development of type 1 diabetes.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. M. Wenzlau, K. Juhl, L. Yu, O. Moua, S. A. Sarkar, P. Gottlieb, M. Rewers, G. S. Eisenbarth, J. Jensen, H. W. Davidson, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes PNAS, October 23, 2007; 104(43): 17040 - 17045. [Abstract] [Full Text] [PDF]